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MINIREVIEW
AT-AC Pre-mRNA Splicing Mechanisms and Conservation of
Minor Introns in Voltage-Gated Ion Channel Genes
QIANG WU† AND ADRIAN R. KRAINER*
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724
Shortly after the discovery of split genes in 1977, a conserved
sequence feature at both ends of cellular and viral introns was
recognized, i.e., the presence of GT at the 59 splice site and AG
at the 39 splice site, giving rise to the so-called GT-AG rule (8).
This rule holds in most cases, but exceptions have been found.
For example, GC is occasionally found at the 59 end of certain
introns (Table 1) (38). GC-AG introns are processed by the
same splicing pathway as conventional GT-AG introns (3). It
had long been assumed that removal of all introns from eu-
karyotic pre-mRNAs took place by the same splicing pathway,
until recent developments demonstrated the existence of a
second pre-mRNA splicing pathway.
Intron 6 of the gene encoding human P120, a proliferating
cell nucleolar antigen, and intron 7 of the gene encoding hu-
man CMP, a cartilage matrix protein (matrilin 1), were the first
reported examples of introns with AT and AC at the intron
ends, instead of GT and AG (38). Intron 6 of the gene encod-
ing Rep-3, a DNA repair protein, and intron 2 of the gene
encoding Prospero, a Drosophila melanogaster homeodomain
transcription factor, also have AT-AC ends (28). In addition to
their distinctive dinucleotide ends, these and other AT-AC
introns have highly conserved 59-splice-site and presumptive
branch site 8-nucleotide sequence elements that are not
present in the major class of introns, ATATCCTY and TCCT
TRAY, respectively. On the basis of these sequence features, it
was proposed that the minor U11 and U12 snRNAs, which
have regions of complementarity to these elements, are re-
quired for splicing of AT-AC introns (28). Important aspects
of this prediction were soon verified experimentally (29, 100),
and two additional minor snRNAs involved in the novel pre-
mRNA splicing pathway were discovered (101).
The AT-AC splicing pathway was originally named after the
distinctive sequences of the intron ends (100). It was later
found that a few introns with AT-AC ends are processed by the
major pathway (120) and, conversely, that some introns with
GT-AG ends are spliced by the minor pathway (18). There-
fore, the name AT-AC no longer reflects the dinucleotide
intron ends per se, but rather it refers to the minor pathway
itself. An alternative designation for the two pathways—U2
dependent and U12 dependent—reflects their observed or ex-
pected requirements for one of the four snRNAs specific to
each pathway (86).
DISTRIBUTION OF AT-AC INTRONS
AT-AC introns exist in a variety of organisms ranging from
Arabidopsis thaliana to Drosophila, Xenopus laevis, and mam-
mals (86, 102, 120). However, AT-AC introns are absent in
budding yeast. There are no obvious structural relationships or
common expression patterns among the genes or gene families
that contain AT-AC introns. The lengths of known AT-AC
introns range from less than 100 bases to more than 3,000
bases (120). The position of AT-AC introns is not conserved
among unrelated genes. However, AT-AC introns are con-
served phylogenetically and within gene families. For example,
the last intron of the CMP gene is an AT-AC intron that is
conserved in human, mouse, and chicken genes (4). Two genes
with an AT-AC intron, mouse Rep-3 (a homologue of bacterial
MutS) and XPG (a gene defective in xeroderma pigmento-
sum), are thought to be involved in DNA repair (120). The
significance of the presence of AT-AC introns in DNA repair
genes may be borne out as more sequences of DNA repair
genes are determined. To date, three gene families have been
noted to have AT-AC introns: the E2F transcription factor
genes, the voltage-gated sodium and calcium channel a subunit
genes (reference 120 and references therein), and the cartilage
matrix protein (matrilin) family genes (4, 109). The voltage-
gated ion channel genes are especially interesting because they
have multiple minor introns; the conservation of minor introns
in these genes is therefore reviewed in detail below.
IN VITRO AND IN VIVO SYSTEMS TO STUDY AT-AC
PRE-mRNA SPLICING
Two different approaches have been used to study the mech-
anisms of AT-AC pre-mRNA splicing. The in vivo approach
consists of transfecting wild-type or mutant minigenes contain-
ing an AT-AC intron and analyzing the splicing patterns after
transient expression. Suppressor AT-AC snRNAs can be co-
transfected with AT-AC intron mutants to test the func-
tional significance of proposed base-pairing interactions be-
tween conserved intron elements and complementary regions
in the snRNAs (29, 37, 45), as originally done for the conven-
tional pathway (129).
The development of in vitro systems for AT-AC pre-mRNA
splicing made it possible to begin to study the biochemical
mechanisms of the reaction. To date, in vitro splicing condi-
tions have been established for processing the AT-AC introns
of pre-mRNAs from two different genes: the gene encoding
P120 and that encoding SCN4A, the voltage-gated skeletal
muscle sodium channel a subunit (100, 119). In vitro splicing of
both P120 and SCN4A pre-mRNAs in HeLa cell nuclear ex-
tract results in generation of a lariat intermediate and release
of the intron as a lariat. Therefore, AT-AC splicing occurs in
two steps involving trans-esterification reactions similar to
* Corresponding author. Mailing address: Cold Spring Harbor Lab-
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those of the major splicing pathway. The results are consistent
in the two AT-AC in vitro splicing systems, but there is one
major difference between them. Inactivation of U1 or U2 snR-
NAs in the nuclear extract is required to detect P120 AT-AC
splicing (100; reviewed in reference 102). This observation led
to the suggestion that U2 may compete with U12, which is
about a hundred times less abundant (64), for binding to the
AT-AC branch site (47). However, this is unlikely to be the
case for SCN4A AT-AC splicing in vitro, which does not re-
quire inactivation of the major splicing pathway (119). In fact,
SCN4A AT-AC splicing and cryptic splicing via conventional
splice sites occur in the same reaction.
FOUR MINOR snRNAs ARE REQUIRED FOR AT-AC
PRE-mRNA SPLICING
AT-AC introns have unique and highly conserved 59-splice-
site and branch site elements, which are recognized by a
unique set of minor snRNAs, U11, U12, U4atac, and U6atac.
These snRNAs lack extensive sequence homology to the major
snRNAs, but they appear to have related secondary structures,
and more importantly, they play analogous roles in splice site
recognition and perhaps in splicing catalysis. Despite the re-
markable parallels, there are some significant differences be-
tween major and minor snRNAs. For example, U11 and U12
form a stable di-snRNP particle (111) that probably enters the
AT-AC spliceosome as a single entity, whereas U1 and U2
are discrete snRNP mono-particles. Although the major U5
snRNA appears to be involved in both splicing pathways (100),
this snRNA assembles onto the major spliceosome as part of a
U4/U6 z U5 tri-snRNP particle, whereas an analogous U4atac/
U6atac z U5 tri-snRNP particle has not yet been described.
Notwithstanding the fact that the AT-AC and major spliceo-
somes have different snRNA constituents, the catalytic core of
the AT-AC spliceosome is thought to resemble that of the major
spliceosome (101; reviewed in references 9, 69, 70, and 102).
U11 and U12 snRNAs. Human U11 and U12 are rare
snRNAs that have Sm antigen binding sites but exhibit no
sequence homology to other snRNAs (64). U11 and U12
snRNP particles presumably contain all the Sm core proteins.
U12 interacts with a fraction of the more abundant U11 to
form a di-snRNP complex (111). A 65-kDa protein of the
U11/U12 complex, identified by virtue of its reactivity with a
scleroderma patient antiserum has been described previously,
although its sequence is not known (25). The predicted sec-
ondary structures of U11 and U12 snRNAs are similar to those
of U1 and U2, respectively (64, 126). U11 and U12 localize in
the nucleoplasm and are concentrated in coiled bodies and
nuclear speckles, but they are excluded from nucleoli (58). This
distribution is very similar to that of the major spliceosomal
snRNAs U1 and U2 (reviewed in reference 89). U12 ortho-
logues have been cloned from mouse, chicken, and frog (103,
126), species in which AT-AC introns are known to exist (re-
viewed in references 86, 102, and 120).
The role of U11 and U12 snRNAs in AT-AC splicing has
been firmly established (29, 45, 100, 119, 125; reviewed in
references 66, 70, and 102). U11 snRNA is present in in vitro-
assembled P120 AT-AC spliceosomes (100) and can be cross-
linked to the P120 AT-AC 59 splice site (125). U11 also inter-
acts with the P120 AT-AC 59 splice site in vivo through base
pairing (45). U12 snRNA is essential for AT-AC splicing in
vitro and in vivo (29, 100, 119). U12 functions in the AT-AC
splicing pathway by base pairing with the highly conserved
branch site sequences (29, 100). Thus, U11 is analogous to U1
snRNA in the major pathway, whereas U12 is analogous to U2.
U11 and U12 snRNPs were also shown to be part of a
negative regulator of splicing complex that inhibits splicing of
Rous sarcoma virus pre-mRNA via the major pathway (26).
This finding suggests a regulatory role for the U11/U12 di-
snRNP particle in addition to its general role in AT-AC pre-
mRNA splicing.
U4atac and U6atac snRNAs. U4 and U6 snRNAs are not
required for AT-AC splicing. U6 is highly conserved between
yeasts and mammals and is thought to function at the catalytic
core of the major spliceosome. This critical role of U6 in the
conventional pathway suggested the existence of an analogous
molecule for the AT-AC pathway (100). The spliceosomal U6
snRNA has a g-monomethyl guanosine triphosphate (meGTP)
cap structure. Several low-abundance snRNAs with a meGTP
cap structure but otherwise structurally distinct from U6 were
identified by immunoprecipitation with antibody specific for
the meGTP cap structure (27). Using the same antibody, two
novel minor snRNAs termed U4atac and U6atac were identi-
fied in affinity-purified AT-AC spliceosomes assembled in vitro
on P120 pre-mRNA (101). U4atac has a trimethylguanosine
cap but coprecipitated because of its tight association with
U6atac, analogous to the interaction between U4 and U6.
U4atac, like U4, is an Sm snRNA. U6atac, like U6, has a
TABLE 1. Compilation of GC-AG intronsa
Gene product Intron no. 59 splice site Size (nt)
SCA2c 9 AGgcaagt 6,600
Protein Zd 2 CTgcaagt NAb
AGLe 17 AGgcaaga 400
LAMA4f 7 AGgcatgg NA
s-Lamining 1 AGgcagag 86
HALh 20 AGgcaagc 2,000
MNKi 9 AGgcaagt 1,200
FAAj 16 AGgcaagc NA
FAA 37 AGgcaaga NA
FAA 41 AGgcaggt NA
CACNL1A3k 32 AGgcacgc 1,000
RYR1l 57 AGgcacgc 596
FE65m 10 AGgcacgg 144
XPGn 3 AGgcaaga NA
Ftnbo 13 AGgcaaga 3,100
Relnp 30 AGgcaagt 1,000
TFIIS.oAq 8 AGgcaagt NA
TGG1r 1 AGgcatgt NA
a 59-splice-site sequences are shown in lowercase letters, with the GC dinucle-
otide in boldface type, and the last two exon nucleotides are shown in uppercase
letters. Six of these genes (those encoding HAL, MNK, CACNL1A3, XPG, Reln,
and TFIIS.oA) also have AT-AC and/or U12-type GT-AG introns (Table 3)
(120). Although nonconsensus introns are very rare, they are unusually prevalent
in these genes, especially those encoding HAL, XPG, FAA, and ion channels.
Twenty-six GC-AG introns described in a previous compilation (38) are not
shown. Some intron sizes are only approximate.
b NA, not available.
c Human spinocerebellar ataxia type 2 protein (83).
d Human vitamin K-dependent plasma glycoprotein (22).
e Human glycogen debranching enzyme (5).
f Human laminin a4 (79).
g Human laminin b2 (20).
h Human histidase (95).
i Human Menkes disease protein (ATP7A) (17, 107).
j Human Fanconi anemia group A (FAA) protein, whose gene has three
GC-AG introns (36).
k Human skeletal muscle voltage-gated calcium channel a subunit (33).
l Human skeletal muscle ryanodine receptor (75).
m Human protein that interacts with b-amyloid precursor protein (34).
n Mouse DNA excision repair protein, defective in xeroderma pigmentosum (54).
o Mouse fertilin beta (15).
p Mouse reelin (81).
q Xenopus transcription elongation factor (76).
r A. thaliana myrosinase; the intron is conserved in other plant homologues
(122, 123).
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meGTP cap structure and terminates with a stretch of U res-
idues, suggesting its transcription by RNA polymerase III.
Both U4atac and U6atac were shown to be essential for in vitro
splicing of the P120 AT-AC intron and subsequently also for
the SCN4A AT-AC intron (101, 120).
The predicted secondary structure of the U4atac/U6atac
snRNA complex is strikingly similar to that of the U4/U6
snRNA complex, although U4atac and U6atac exhibit only
about 40% overall sequence homology to U4 and U6, respec-
tively (101). In the central region of U6atac, the homology to
U6 is much greater, about 80%, and this region includes sites
that can be cross-linked to U12 with psoralen. U6atac, which
has an AAGGAGA box at the region corresponding to the
ACAGA box of U6, base pairs with the AT-AC 59 splice site,
replacing U11 (37, 125). The U6atac-U12 helix identified by
psoralen cross-linking is analogous to a U6-U2 helix thought to
be part of the major spliceosome active site, which strongly
suggests that U6atac likewise functions at the catalytic core of
the AT-AC spliceosome (101). U4atac appears to act as a
chaperone for U6atac, similar to the role of U4 vis-a`-vis U6
(101). U5 is apparently required for splicing of both AT-AC
and GT-AG introns (100, 120). Whether U5 base pairs with
AT-AC exon borders, as has been shown for conventional exon
sequences (reviewed in reference 68), remains to be determined.
AT-AC SPLICE SITE RECOGNITION
The mechanisms by which conventional splice sites are se-
lected with high fidelity in metazoan pre-mRNAs remain
largely unknown (reviewed in reference 7). The short, degen-
erate splice site and branch site elements are clearly required
for proper splice site recognition, but they are not sufficient
(93). The arrangement, spacing, and sequence context of the
splice sites probably also contribute to accurate splice site
selection.
In the case of AT-AC introns, even though the 59-splice-site
and branch site sequences are highly conserved 8-nucleotide
elements, they probably lack sufficient information to specify
AT-AC splice site recognition. Genomic sequences contain
many pairs of sequences that match the AT-AC 59-splice-site
and branch site elements, but probably only a few of these are
authentic AT-AC intron elements. Therefore, the sequence
complementarity between the minor snRNAs and the AT-AC
59-splice-site and branch site sequences is not sufficient to
accurately select AT-AC splice sites. As with conventional
introns, additional mechanisms and/or auxiliary signals for
AT-AC splicing may help identify the authentic splice sites.
For example, the arrangement, spacing, and sequence context
of AT-AC splice sites within the entire pre-mRNA, as well as
the presence of intronic and exonic elements, are likely to
contribute to accurate splice site selection.
Exon definition interactions between the AT-AC and major
spliceosomes. Most vertebrate genes have multiple introns,
which are usually very large, whereas the exons are relatively
small (30, 94). Sequences within large introns can match the
degenerate splice site consensus elements, but they are not
recognized by the spliceosome, at least in the presence of the
wild-type splice sites. The exon definition model (reviewed in
reference 6) proposes that in pre-mRNAs with large introns,
the splicing machinery initially recognizes a pair of splice sites
around a short exon and assembles on the exon; subsequently,
neighboring exons are juxtaposed (80). Thus, the sequences
within large introns need not be recognized. In lower eu-
karyotes, or in the case of small introns, a pair of splice sites at
the ends of the short intron is directly recognized by the splice-
osome, by an intron definition mechanism (97). Exon defini-
tion and intron definition are probably not mutually exclusive.
Both types of interactions may occur simultaneously to facili-
tate the recognition of multiple splice sites.
The exon definition model predicts that in genes with mul-
tiple introns, exons and their flanking introns cannot both be
large. Indeed, large introns are usually flanked by small exons
and large exons are usually flanked by small introns (94, 128).
Statistical analyses of the length of vertebrate internal regu-
lated exons and primate internal exons showed that very large
exons and very small exons are very rare (6, 91). Several lines
of experimental evidence have given strong support to the exon
definition model. First, mutation of a downstream 59 splice site
inhibits splicing of the upstream intron (97). Second, strength-
ening the downstream 59 splice site increases the splicing effi-
ciency of the upstream intron (49). Finally, joining a 59 splice
site to the end of the downstream exon increases the splicing
efficiency of the upstream intron in vitro (48). Numerous cases
of splice site mutations in vertebrate genes cause exon skipping
rather than intron retention (46, 67). These phenomena are
consistent with the exon definition model, although exon skip-
ping can also be explained by cis-competition between splice
sites or, in some cases, by instability of the retained-intron
RNAs because of blocked mRNA export and/or nonsense-
mediated mRNA decay. Evidence for the recognition of ter-
minal exons also supports the exon definition model. Compo-
nents that bind to the 59 cap cooperate with the splicing
machinery to facilitate the recognition of the first exon (52).
Definition of the last exon involves cross talk between the
splicing and polyadenylation machineries (71).
After exon definition, the correct exons must be ligated. The
mechanisms responsible for the correct juxtaposition of exons
are poorly understood. Members of the SR protein family, a
group of essential pre-mRNA splicing factors with character-
istic arginine-serine C-terminal repeats (RS domain) and one
or two N-terminal RNA-recognition motifs, may play a bridg-
ing role for exon juxtaposition, since they can bind to exon
sequences and also can interact with themselves (14, 92, 116).
SR proteins can interact with U1-70K, a U1 snRNP-associated
protein, and U2AF, a U2 auxiliary factor (116). It is thought
that SR proteins can bridge partially assembled spliceosomes
on neighboring exons through U1-70K and U2AF. Splicing
factor 1 (SF1) may also play a bridging role for exon juxtapo-
sition. SF1 interacts with both U2- and U1-associated factors
(1, 78).
Because AT-AC introns always coexist with multiple major
introns, the question arises whether exon definition interac-
tions take place between the two different classes of introns.
Indeed, in vitro splicing of the SCN4A AT-AC intron 2 is
strongly stimulated when exon 3 is followed by the conven-
tional 59 splice site of intron 3. More importantly, the stimu-
latory effect is dependent on intact U1 snRNP (119, 121).
Therefore, U1 bound at the downstream 59 splice site interacts
with the upstream AT-AC splicing machinery in vitro (Fig. 1).
A 4-base deletion in the conventional 59 splice site of SCN8A
intron 3 results in complete skipping of exons 2 and 3 in vivo
(43). This is probably due to disruption of exon definition
interactions between the AT-AC intron 2 and the conventional
intron 3. The fact that exon 2 does not join to exon 4 implies
that an AT-AC 59 splice site and a conventional 39 splice site
are incompatible, i.e., that the AT-AC 59 spliceosomal compo-
nents and the conventional 39 spliceosomal components cannot
be bridged by intron definition. Consistent with this idea, re-
placement of the SCN4A AT-AC intron 2 branch site element
with a conventional branch site abrogates AT-AC splicing in
vitro, resulting in stimulation of the conventional pathway via
a pair of cryptic splice sites (118).
Exon definition interactions between the major and minor
VOL. 19, 1999 MINIREVIEW 3227
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spliceosomes presumably involve indirect contacts between the
major and minor snRNPs (Fig. 1). Whether exon definition can
also take place between a downstream AT-AC intron and an
upstream conventional intron is not known. The question also
arises how the terminal exons are defined in the context of
AT-AC introns, which are occasionally the first or the last
intron. For example, the AT-AC intron in the calcium channel
CACNL1A4 gene is the first intron (73), whereas the AT-AC
introns in the matrilin family genes (4, 109) and GT335, a gene
of unknown function (50), are the last intron of their respective
genes. Therefore, it will be of interest to determine whether
terminal exons can be defined by interactions between the
AT-AC splicing machinery with 59-cap recognition compo-
nents or the polyadenylation machinery.
Purine-rich enhancers contribute to AT-AC splice site rec-
ognition. In addition to splice site interactions that take place
via intron or exon definition, splice site selection can also be
facilitated by exonic and/or intronic sequences. Splicing en-
hancers are elements that contribute to the recognition of
authentic splice sites. The actual prevalence of these elements
is not yet known. Purine-rich sequences characteristic of most
natural exonic splicing enhancers (ESEs) characterized to date
are present in a wide variety of cellular and viral genes in
metazoans. Purine-rich sequences have also been shown to
modulate plant 59 splice-site selection (61). In metazoans, pu-
rine-rich ESEs are recognized by members of the SR protein
family. Purine-rich enhancers are usually composed of GAR
repeats (R represents a purine nucleotide) but not runs of G or
A (35, 98). However, G-rich repeats typical of small intron
sequences in vertebrate genes may facilitate the recognition of
splice sites in small introns (60). Non-purine-rich splicing en-
hancers can also stimulate splicing (16, 53, 104, 105).
Some exons downstream of known AT-AC introns have
purine-rich sequences that closely resemble those present in
natural enhancers of the major splicing pathway (Table 2),
raising the question of whether purine-rich sequences can act
as AT-AC splicing enhancers. Indeed, heterologous purine-
rich sequences that function as enhancers in the conventional
pathway also strongly stimulate AT-AC splicing when placed in
the context of a downstream exon that naturally lacks such
sequences (121). The purine-rich sequences that are present in
many exons flanking AT-AC introns may be natural AT-AC
splicing enhancers, or they may influence splicing of both con-
ventional and AT-AC introns on either side. It will be inter-
esting to determine whether non-purine-rich exonic enhancers
or intronic enhancers can also function in the AT-AC splicing
pathway. The finding that purine-rich enhancers can function
in the AT-AC splicing pathway suggests that the enhancer-
specific functions of SR proteins are relevant to the AT-AC
splicing pathway. If this is the case, an important question is
whether SR proteins interact with overlapping or with distinct
components of the major and minor spliceosomes to mediate
splicing enhancement.
In the major splicing pathway, both the downstream 59 splice
site and purine-rich enhancers contribute to the selection of
the upstream splice site and appear to involve the action of SR
proteins (reviewed in references 6, 7, 10, and 57). In addition,
the U1 snRNP has also been implicated in enhancer function:
U1 snRNA has been cross-linked to a purine-rich enhancer
(112) and is present in an in vitro-assembled enhancer complex
(90, 92). SR proteins facilitate U1 binding to 59 splice sites (21,
44, 127), and it follows that SR proteins bound to purine-rich
enhancers may also recruit U1 (reviewed in references 10, 57,
and 108). However, intact U1 snRNP is not required for the
stimulation of AT-AC splicing by purine-rich enhancers in
vitro (121). Therefore, enhancer function and exon definition
FIG. 1. Exon definition interactions between consecutive minor and major
introns. Components of the minor and major spliceosomes interact across the
intervening exon. The spliceosomes are denoted by the ellipses. U11 and U12 are
shown bound to the AT-AC 59 splice site and branch site, respectively, and U1
and U2 are shown bound to the conventional 59 splice site and branch site,
respectively. The interaction across the exon requires U1 snRNA base pairing at
the conventional 59 splice site. Bound U1 snRNP probably interacts indirectly
with U12 snRNP components, perhaps through bridging by SR proteins. U11
and U12 form a di-snRNP particle, although it is not known if their interactions
are maintained in the spliceosome.
TABLE 2. Exonic purine-rich sequences present downstream of known AT-AC intronsa
Gene
product Exon no. Sequence
P120b 7 ...AGCGGGAGGAAGGGCGG...CTCAAGAAGGATCT...
CMPc 8 ...CCTGGAGAACAC...
GT335d 7 ...GGTGAGGAAGGTGCTGGAACTCACTGGAAAGTGA...
CDK5e 10 ...GACGAGGAACAA...
REP-3f 7 ...TACGAAGAAAAGGAGAACAT...GACAAAAAGAAGGGGAACCT...
HPSg 16 CTACCTGGAGGATTT...AACGAAAAGATGT...GGCAAGGGGCCC...
TFIIS.oAh 7 ...CCTGAGAAGAAATGT...
a Stretches of six or more consecutive purines are shown in boldface type. Each set of three dots represents a flanking or connecting exon segment longer than three
nucleotides that is not shown. The exon sizes range from 44 to 200 nucleotides, except for the last exons. The spacing between the indicated purine segments and the
preceding 39 splice site ranges from 6 to 136 nucleotides.
b Human proliferating cell nucleolar antigen (GenBank accession no. M33132).
c Human cartilage matrix protein (GenBank accession no. M55682).
d Human protein of unknown function (GenBank accession no. U53007).
e Mouse neuronal cyclin-dependent kinase (GenBank accession no. D29678).
f Mouse protein involved in DNA mismatch repair (GenBank accession no. L10301).
g Mouse protein defective in Hermansky-Pudlak syndrome (GenBank accession no. U78964).
h Frog transcription elongation factor (GenBank accession no. X97662).
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are mechanistically different, at least in terms of a requirement
for U1.
In the major pathway, ESEs and the downstream 59 splice
site facilitate recognition of the upstream 39 splice site by
specific interactions with SR proteins. These proteins appar-
ently interact with the essential splicing factor U2AF, facilitat-
ing its binding to the 39-splice-site polypyrimidine tract, while
U2AF in turn promotes binding of U2 to the branch site (31,
130). The 39 region of AT-AC introns differs from that of
conventional introns: the former lack a polypyrimidine tract,
and the branch site is much closer to the 39 splice junction.
These differences suggest that the AT-AC spliceosomal com-
ponents involved in recognition of the 39 splice site are differ-
ent from those of the conventional spliceosome. Surprisingly,
despite these differences, both a downstream 59 splice site and
purine-rich enhancers stimulate AT-AC splicing, suggesting
that both contribute to AT-AC splice-site selection, as they do
in the major splicing pathway. Although in the AT-AC splicing
pathway both exonic enhancers and a downstream conven-
tional 59 splice site are also expected to interact with spliceo-
somal components at the upstream 39 splice site, some of these
components may be unique to the AT-AC splicing pathway.
A DIVERGENT SUBCLASS OF AT-AC INTRONS
In vitro studies showed that splicing of the SCN4A intron 2
occurs by the AT-AC splicing pathway, and this is probably
also the case for the homologous introns in the voltage-gated
sodium and calcium channel genes (119, 120). Interestingly,
the SCN4A gene has another unusual intron, intron 21, which
has 59-AT and AC-39 ends (24, 59, 120), as does the corre-
sponding intron 25 of the SCN5A gene (110, 120). However,
the 59-splice-site and branch site elements of these two introns
do not match the highly conserved AT-AC 59-splice-site and
branch site consensus sequences, suggesting that these diver-
gent introns belong to a distinct subclass of AT-AC introns
(119). Indeed, in vitro splicing of these two sodium channel
introns, termed AT-AC II, requires the major U1, U2, U4, U5,
and U6 spliceosomal snRNAs, rather than the minor AT-AC
snRNAs (120). Other AT-AC II introns have previously been
described in the chicken parvalbumin gene and in xylanase
genes of several filamentous fungi (120).
The vast majority of introns have GT and AG boundaries at
the intron 59 and 39 ends, respectively. The importance of the
intron ends is underscored not only by in vitro and in vivo
mutational analyses (3) but also by the fact that splice site
mutations impair gene expression and cause numerous human
genetic diseases (46, 67). On the other hand, previous muta-
tional analyses showed that certain splice site mutations are
compatible with accurate splicing. For example, in the yeast
actin intron and a human tropomyosin intron, mutation of G to
A at the first position or G to C at the last position compro-
mises splicing; however, the double mutation at both ends of
these introns allows accurate splicing in vivo, albeit less effi-
ciently (13, 74, 85). The double mutations generate 59-AT and
AC-39 intron boundaries. Although these observations pre-
ceded the discovery of a unique AT-AC splicing pathway, a
possible explanation of these results is that the double-mutant
pre-mRNAs were processed by the minor pathway. This ap-
pears unlikely, because the double-mutant intron sequences do
not match the highly conserved AT-AC 59-splice-site and
branch site consensus (66). Although the snRNA requirements
for splicing of the mutant introns have not been determined, it
is likely that they are processed by the major pathway, by
analogy to the natural AT-AC II introns, which require the
major snRNAs (120). The mutational results were interpreted
to suggest a non-Watson-Crick interaction between the first
and last bases of the introns. Analysis of the splicing of introns
with inosine inserted at the intron ends supports this model
(85, 99). The non-Watson-Crick interaction between the intron
ends probably exists in the natural AT-AC II introns and prob-
ably also exists in all AT-AC introns. On the other hand, the
observed lack of specificity in selection of the last nucleotide of
a yeast intron argues against a direct interaction between the
first and last bases of introns (55).
Although the splice site sequences and the positions of the
SCN4A AT-AC II intron 21 and SCN5A AT-AC II intron 25
are conserved, the lengths of these two introns are different.
The longer SCN4A AT-AC II intron 21 contains an Alu repeat
insertion at nucleotides 358 to 660 (numbering as per Gen-
Bank entry AF007782) (117). Alu sequences are repetitive
elements that are unique to primates and are thought to be
derived from the 7SL RNA (reviewed in reference 62). The
functions of Alu sequences are unclear, although in some cases
they can influence gene expression. Alu sequences contain
several regions that differ from either 59 or 39 splice site con-
sensus elements by only one or two nucleotides. When Alu
sequences are present within conventional introns, they can
have dramatic effects on splicing (reviewed in reference 56).
Point mutations can activate cryptic splice sites in intronic Alu
elements and result in abnormal protein formation and clinical
disease, e.g., Alport syndrome and ornithine delta-aminotrans-
ferase deficiency (41, 63). Mutations in the SCN4A gene cause
hyperkalemic periodic paralysis and paramyotonia congenita
(reviewed in reference 32). Whether there are natural muta-
tions of this gene that involve activation of cryptic splice sites
within the Alu insertion in intron 21 or whether this Alu in-
sertion has any functional consequences remains to be seen.
U12-TYPE GT-AG INTRONS
AT-AC II introns have 59-AT and AC-39 boundaries, yet
their splicing requires the major spliceosomal snRNAs (120).
Conversely, some introns that have 59-GT and AC-39 bound-
aries are spliced by the minor spliceosomal snRNAs (18). With
the exception of the first and last nucleotides, which are both
G, the sequences of these introns match the AT-AC splice site
and branch site consensus elements (Tables 3 and 4). This
subclass of GT-AG introns has been termed U12-type GT-AG
introns (86). Recent compilations showed that U12-type
GT-AG introns are more prevalent than AT-AC introns (18,
86). Additional examples of this type of intron are shown in
Tables 3 and 4. Interestingly, XPG- and CDK5-encoding genes
contain both an AT-AC intron and a U12-type GT-AG intron
(54, 72). Likewise, the members of the voltage-gated ion chan-
nel a subunit gene family have several unconventional introns
(see below). Intron 2 of the gene encoding human CACNLB3,
the voltage-gated calcium channel b subunit, also belongs to
the U12-type GT-AG intron class.
OTHER NATURAL INTRON BOUNDARIES
AT-AA introns. Previous studies showed that a G-to-A mu-
tation at the last position of a major class intron can partially
suppress a G-to-A mutation at the first position of the intron in
vivo (11, 74). To date, three natural AT-AA introns are known:
intron 6 of the gene encoding the DNA excision repair protein
hMSH3 (113); intron 7 of the gene encoding Arabidopsis AtG5
(115); and intron 3 of the gene encoding pig succinyl-coenzyme
A (CoA) synthetase (82) (Table 5). Intron 6 of the gene en-
coding hMSH3 and intron 7 of the gene encoding AtG5 have
the AT-AC 59-splice-site consensus. Intron 6 of the gene en-
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coding hMSH3 also has the AT-AC branch site consensus and
is the homologous intron of the AT-AC intron 6 of the Rep-3
gene. Therefore, this intron is almost certainly processed via
the AT-AC pathway. The corresponding intron 6 of the related
hMSH5 gene is a U12-type GT-AG intron (Table 3). Interest-
ingly, in alternative splicing of hMSH2, another related DNA
repair gene, intron 12 was reported to have unusual TA-TT
ends (65). Although the AT-AA intron 7 of the gene encoding
AtG5 may be processed by the AT-AC pathway, this assump-
tion needs to be verified experimentally, since the intron lacks
a good match to the AT-AC branch site consensus. Intron 3 of
the gene encoding pig succinyl-CoA synthetase is alternatively
spliced and lacks the AT-AC 59-splice-site and branch site
consensus. Therefore, splicing of this intron likely requires the
major snRNAs.
AT-AG introns. Mutation of the first nucleotide from G to A
of a major-class intron inhibits the second step of splicing in
vitro (13, 74, 85). Many natural mutations giving rise to various
genetic diseases consist of G-to-A mutation at the first position
of an intron, with the consequent impairment of gene expres-
sion (46, 67). For example, this type of mutation in intron 1 of
the human b-globin gene prevents normal splicing, activates
three cryptic 59 splice sites, and causes thalassemia (106); in
intron 5 of the human adenosine deaminase gene, it results in
severe immunodeficiency (84); in intron 5 or intron 18 of the
human myosin VIIA gene, it causes Usher syndrome type IB
(2). These in vitro and in vivo observations suggested that
59-AT and AG-39 boundaries within the same introns are in-
compatible. This is likely to be true in the context of the major
splicing pathway, so the few natural examples of AT-AG in-
trons are likely to be processed via the minor splicing pathway.
Three natural introns have 59-AT and AG-39 ends: intron 38
of the myosin VIIa gene (40, 51), which codes for a long-tailed
unconventional myosin; intron 2 of CACNL1A1 (87); and in-
tron 24 of SCN10A (88). Intron 38 of the myosin VIIa gene has
the 59-splice-site and presumptive branch site sequences ATA
TCCGT and TCCTTGAC, respectively, as independently re-
ported by two different groups (40, 51). These sequences are
close matches to the AT-AC consensus elements. The introns
corresponding to intron 2 of CACNL1A1 in other voltage-
gated calcium channel a subunit genes are either of the
AT-AC class or of the U12-type GT-AG class. Thus, splicing
of all three types of introns presumably requires the minor
snRNAs, although this assumption needs to be confirmed ex-
perimentally. Splicing via the minor pathway would account for
the tolerance to 59-AT and AG-39 intron ends (see below).
DIFFERENTIAL TOLERANCE TO MUTATION OF THE
LAST INTRON NUCLEOTIDE IN AT-AC AND
CONVENTIONAL SPLICING
Most natural AT-AG and AT-AA introns have close
matches to the highly conserved AT-AC 59-splice-site and
branch site consensus sequences. The distances between the
branch site and the 39-splice junction are all very short. There-
fore, it appears that the AT-AC spliceosome tolerates changes
TABLE 3. Compilation of U12-type GT-AG intronsa
Gene product Intron no. 59 splice site Presumptive branch site 39 splice site Distance (nt) Size (nt)
MDCc 11 AGgtatcctc ... ctcac ccctcagGG 9 109
HALd 3 CTgtatcctt ... NAb ctggatacagAT NA 100
HAL 6 AGgtatcttt ... NA tttattctagTT NA 100
HAL 15 CTgtatcttt ... NA cttttgaaagAT NA 3,000
MNKe 11 AGgtatttat ... atgttaac ttatatccagTG 12 1,000
BMP1f 15 AGgtatcc ... NA ttctgttgctccagTC NA NA
BMP1 15 ... NA ctctctcgtttcagAA NA NA
BMP1 15 ... NA ttgctcccctgcagAG NA NA
CACNL1A1g 15 CTgtatcctt ... NA acacaaacagAT NA 1,600
CACNL1A2h 16 CTgtatcctt ... cccttaaa aagttgaaattagAT 15 3,400
CACNL1A3i 13 CTgtatcctc ... tccttagc taaacccgctcagAC 15 900
CACNL1A4j 16 CTgtatcctt ... tcctgact cagacatttgcagAC 15 155
CACNLB3k 2 AGgtatactt ... gcactaat gggcaaattctccagCA 17 216
MSH5l 6 TGgtatctcc ... ccctcaaa tagGT 5 733
Relnm 27 AGgtatct ... tccttcac tagCT 5 2,000
SCN10An 8 AGgtatctt ... cccttgaa tctccagAC 9 300
XPGo 1 GGgtatcctt ... tcctttac tggttcccccagAT 14 NA
CDK5p 6 GGgtatctgt ... NA ctcccctcagAA NA 470
a Sequences around the 59 splice site, 39 splice site, and presumptive branch site of U12-type introns are shown. The U12-type GT-AG introns described in previous
compilations (86) are not shown. See also the SCN10A intron 2 in Table 4. Intron sequences are shown in lowercase letters, flanked by two exon nucleotides on each
side, shown in uppercase letters. The consensus positions at the 59 splice site, 39 splice site, and presumptive branch site are shown in boldface type for nearly invariant
nucleotides and are underlined for conserved purines or pyrimidines. The three dots indicate sequences that are either not shown or not known. Distance refers to the
number of nucleotides from the branch nucleotide to the 39 splice junction. Some of the intron sizes are only approximate.
b NA, not available.
c Human metalloprotease-like, disintegrin-like, cysteine-rich protein (39).
d Human histidase protein, whose gene has three U12-type GT-AG introns (95).
e Human Menkes disease protein (ATP7A) (17, 107).
f Human bone morphogenic protein 1/tolloid. The 59 splice site is alternatively spliced to three different 39 splice sites (96).
g Human fibroblast voltage-gated L-type calcium channel a subunit (87).
h Human pancreatic voltage-gated calcium channel a subunit (124).
i Human skeletal muscle voltage-gated calcium channel a subunit (33).
j Human brain-specific P/Q-type voltage-gated calcium channel a subunit (73).
k Human voltage-gated calcium channel b subunit (124).
l Human homologue of the Saccharomyces cerevisiae MSH5 protein (114).
m Mouse reelin (81).
n Mouse sensory neuronal voltage-gated sodium channel a subunit (88).
o Mouse DNA excision repair protein defective in xeroderma pigmentosum (54).
p Mouse neuronal cyclin-dependent kinase (72).
3230 MINIREVIEW MOL. CELL. BIOL.
 o
n
 D
ecem
ber 11, 2013 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
in the last intron nucleotide, which can be either C, A, or G.
Indeed, a recent in vivo mutational analysis of the last nucle-
otide of the AT-AC intron in the P120 gene showed that
although C-to-G mutation results in activation of a pair of
conventional cryptic splice sites, accurate splicing via the
AT-AC pathway can still occur (18).
The 59-AT and AG-39 boundaries of the CACNL1A1 intron
2 may represent an evolutionary transition between the
AT-AC introns in the voltage-gated sodium channel a subunit
genes and the U12-type GT-AG introns within the homolo-
gous domain I of the voltage-gated calcium channel a subunit
genes. Intron 2 of mouse SCN10A, which has a GTGTCC 59
splice site and a canonical AT-AC branch site (Table 4), may
represent a further evolutionary transition from a U12-type
GT-AG intron to a conventional intron. The 59-AT and AA-39
boundaries of hMSH3 intron 6 represent a drift from the cor-
responding AT-AC intron 6 of the homologous mouse Rep-3
gene. The 59-GT and AG-39 boundaries of hMSH5 represent a
further drift. The major spliceosome has a more stringent
sequence requirement for the last intron nucleotide, which can
only be a G, unless the first nucleotide is simultaneously mu-
tated. Conversely, in AT-AC II introns, the last nucleotide
presumably has to be a C, unless the first nucleotide changes
simultaneously. It is probably difficult for an AT-AC II intron
to evolve into a conventional intron, or vice versa, because this
would require simultaneous mutations at both ends of the
intron. In contrast, AT-AC introns may more easily evolve
gradually into conventional introns. The last nucleotide, C, can
be first mutated to G, then the first nucleotide, A, can be
mutated to G, and splicing would still be catalyzed by the
minor spliceosome. Then the 15 position of the 59 splice site
can change from C to G. This last mutation may be sufficient
for switching from the minor splicing pathway to the major
splicing pathway and would likely constitute an irreversible
switch, since AT-AC introns have highly conserved 59-splice-
site and branch site elements, whereas conventional introns
have much more degenerate elements.
COMMITMENT TO A SPECIFIC SPLICING PATHWAY
The dinucleotides at the intron ends are not responsible for
commitment of a pre-mRNA to the major or the minor splic-
ing pathway (18, 120). Likewise, the highly conserved AT-AC
branch site consensus sequence (UCCUURAY) recognized by
U12 snRNA is probably not the major determinant of com-
mitment to the minor pathway, since it also matches the de-
generate consensus for conventional branch sites (YNYU
RAY), and therefore it should also be recognized by the abun-
TABLE 4. Minor intron conservation in voltage-gated sodium and calcium channel a subunit genesa
Gene product Intron no. 59 splice site Presumptive branchsite 39 splice site Distance (nt) Size (nt)
SCN4Ac 2 GCatatcctg ... tccttgac cctgccccacGC 12 126
SCN5Ad 3 TCatatcc ... NAb cccacgcacGC NA NA
SCN8Ae 2 TCatatcctt ... cccttaac tcctctctacAG 12 NA
SCN10Af 2 TCgtgtcct ... tccttaac atggacctcacagCT 15 4200
CACNL1A1g 2 AAatatcctt ... tccttgac tccctttctcagAC 14 5000
CACNL1A2h 2 AAgtatcctt ... accttaac acattttttcagAC 14 4800
CACNL1A3i 1 AAgtatcctt ... tccttaac cctgctccagGC 12 600
CACNL1A4j 1 CCatatcctt ... tccttaat tccccaatacTC 12 NA
a Sequences around the 59 splice site, 39 splice site, and presumptive branch site of the minor introns are shown. The minor introns interrupt a homologous position
of the coding sequence in all eight members of the voltage-gated sodium and calcium channel a subunit genes. Smaller subsets of these sequences were shown in
previous compilations (18, 119, 120). Intron sequences are shown in lowercase letters, flanked by two exon nucleotides on each side, shown in uppercase letters. The
consensus positions at the 59 splice site, 39 splice site, and presumptive branch site sequences are shown in boldface for nearly invariant nucleotides and are underlined
for conserved purines or pyrimidines. The three dots indicate sequences that are either not shown or not known. Distance refers to the number of nucleotides from
the branch nucleotide to the 39 splice junction. Some of the intron sizes are only approximate.
b NA, not available.
c Human skeletal muscle voltage-gated sodium channel a subunit (24, 59).
d Human cardiac muscle voltage-gated sodium channel a subunit (110).
e Mouse brain and spinal cord voltage-gated sodium channel a subunit (43).
f Mouse sensory neuronal voltage-gated sodium channel a subunit (88).
g Human fibroblast L-type voltage-gated calcium channel a subunit (87).
h Human pancreatic voltage-gated calcium channel a subunit (124).
i Human skeletal muscle voltage-gated calcium channel a subunit (33).
j Human brain-specific P/Q-type voltage-gated calcium channel a subunit (73).
TABLE 5. Compilation of known AT-AA intronsa
Gene
product Intron no. 59 splice site
Presumptive
branch site 39 splice site Distance (nt)
Size
(nt)
hMSH3c 6 AGatatcctt ... tctttaat tattattaaAT 11 2,000
AtG5d 7 AAatatcctt ... atattaac caaggcttaaGT 12 138
SCSe 3 TGataagt ... tttttgaa ttctccttctttaaGG 16 NAb
a Sequences around the 59 splice site, 39 splice site, and presumptive branch site of the AT-AA introns are shown. Intron sequences are shown in lowercase letters,
flanked by two exon nucleotides on each side, in uppercase letters. The consensus positions at the 59-splice-site, 39-splice-site, and presumptive branch site sequences
are shown in boldface for nearly invariant nucleotides and are underlined for conserved purines or pyrimidines. The three dots indicate sequences that are either not
shown or not known. The distance refers to the number of nucleotides from the branch nucleotide to the 39 splice junction. The hMSH3 intron size is only approximate.
b NA, not available.
c Human homologue of the bacterial DNA mismatch repair protein MutS (113).
d A. thaliana putative transmembrane protein (115).
e Pig heart succinyl-CoA synthetase (82).
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dant U2 snRNA. Intron 7 of the xylanase xylP gene in the
filamentous fungus Penicillium chrysogenum has a sequence
identical to the AT-AC branch site consensus, but it is proba-
bly processed via the major splicing pathway (120). It is likely
that the highly conserved AT-AC 59 splice site, which is rec-
ognized by U11 and U6atac snRNAs, is the major determinant
of commitment to the AT-AC splicing pathway. An AT-AC
branch site sequence is of course also required but is probably
compatible with either pathway. The lack of an extensive poly-
pyrimidine tract and the short distance between the branch site
and the 39 splice site in AT-AC introns probably also contrib-
ute to their specific commitment to the AT-AC splicing pathway.
MULTIPLE MINOR INTRONS IN VOLTAGE-GATED ION
CHANNEL GENES
The voltage-gated sodium channel and calcium channel a
subunit genes belong to the voltage-gated ion channel gene
superfamily. Mutations in these genes cause numerous neuro-
muscular and neurological diseases (reviewed in reference 19).
The genes have four internal homologous domains (I to IV)
that are thought to arise from two rounds of duplication from
a single ancestral gene (Fig. 2) (12, 42). Interestingly, these
genes have two or sometimes three nonconsensus introns (Fig.
2; Tables 3, 4, and 6). Multiple sequence alignments of the
FIG. 2. Topology of voltage-gated ion channel proteins and positions of the unusual introns. The diagram shows the proposed topology of the voltage-gated sodium
and calcium channel a subunit protein families (12, 42). Domain repeats I through IV (DI through DIV) are indicated at the top. Within each domain repeat, the six
membrane-spanning segments are shown in blue, and the connecting loops are shown in gray. The positions of unusual introns that interrupt the coding sequences of
the corresponding genes are indicated. For some of these introns, the first and last nucleotides are not invariant among different family members (Tables 4 and 6). The
conservation of the position of the AT-AC introns (yellow rectangles) in domain I of the sodium and calcium channel genes is indicative of the presence of this intron
prior to the divergence of these two gene families. The U12-type GT-AG introns (red circles) are present at different positions of the sodium and calcium channel genes.
The AT-AC II intron (green square) is only present in the sodium channel genes. Some family members have lost one or more of these introns or have conventional
introns at the same position. Each type of intron interrupts a different part of the domain repeat coding sequence, and hence each intron at the four indicated locations
in the voltage-gated ion channel genes probably arose independently.
TABLE 6. AT-AC II intron conservation in voltage-gated sodium channel a subunit genesa
Gene product Intron no. 59 splice site Presumptive branchsite 39 splice site Distance (nt) Size (nt)
SCN4Ac 21 AGatgagtat ... acctgac ... ccactatacTT 21 822
SCN5Ad 25 AGatacgtgg ... ctctgag ... tctttgcacTT 37 680
SCN8Ae 21 AGataggtct ... NAb cctcctttacacTT NA NA
SCN10Af 24 AGataagtg ... cgttaat tcctcccccctagTT 15 900
a Sequences around the 59 splice site, 39 splice site, and presumptive branch site of the minor introns are shown. The minor introns interrupt a homologous position
of the coding sequence in all four voltage-gated sodium channel a subunit genes. The sequences of the first two introns were shown in a previous compilation (120).
Intron sequences are shown in lowercase letters, flanked by two exon nucleotides on each side, in uppercase letters. The consensus positions at the 59-splice-site,
39-splice-site, and presumptive branch site sequences are shown in boldface for nearly invariant nucleotides and are underlined for conserved purines or pyrimidines.
The three dots indicate sequences that are either not shown or not known. Distance refers to the number of nucleotides from the branch nucleotide to the 39 splice
junction. The sizes of the SCN4A intron 21 and the SCN5A intron 25 are according to GenBank accession no. AF007782 and AF007781, respectively. The size of
SCN10A is only approximate.
b NA, not available.
c Human skeletal muscle voltage-gated sodium channel a subunit (24, 59, 120). Reference 59 reported TA as the 39 splice site dinucleotide.
d Human cardiac muscle voltage-gated sodium channel a subunit (110, 120).
e Human neuronal voltage-gated sodium channel a subunit (77).
f Mouse sensory neuron voltage-gated sodium channel a subunit (88).
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different family members show that these introns interrupt the
genes at exactly homologous positions of the coding sequence
(Fig. 3).
SCN4A, SCN5A, and SCN8A, the voltage-gated sodium
channel a subunit in skeletal muscle, cardiac muscle, and brain
and spinal cord, respectively, have two rare introns: an AT-AC
intron and an AT-AC II intron (43, 77, 120; Fig. 2). The
AT-AC intron interrupts the coding sequence of internal do-
main I, while the AT-AC II intron is located between domains
III and IV. Interestingly, the corresponding AT-AC intron 2 of
the mouse gene encoding SCN10A, the sensory neuron volt-
age-gated sodium channel a subunit, has the sequence GTGT
CCT at the 59 splice site and AG as the 39-splice-site dinucle-
otide (Table 4) (88). The voltage-gated calcium channel a
subunit genes also have an unusual intron at precisely the same
position within domain repeat I (Fig. 2 and 3A). However,
these introns have different boundaries (Table 4): intron 2 of
the gene encoding CACNL1A1, the fibroblast L-type voltage-
gated calcium channel a subunit, has 59-AT and AG-39 bound-
aries; intron 1 of the gene encoding CACNL1A4, the brain-
specific P/Q-type voltage-gated calcium channel a subunit, has
59-AT and AC-39 boundaries; and intron 2 of the gene encod-
ing CACNL1A2, the pancreatic voltage-gated calcium channel
a subunit, and intron 1 of the gene encoding CACNL1A3, the
skeletal muscle voltage-gated calcium channel a subunit, have
59-GT and AG-39 boundaries. All eight introns have the highly
conserved AT-AC branch site element. The same kind of in-
tron is expected to be present in other voltage-gated sodium
and calcium channel a subunit genes and to be processed via
the AT-AC splicing pathway (120). Splicing of an intron of the
ADP ribose polymerase gene, which has the features of U12-
type GT-AG introns, requires the minor U12 and U6atac
snRNAs (18). It is therefore very likely that the GT-AG in-
trons in CACNL1A2 (CACN4) and CACNL1A3 are also pro-
cessed via the minor pathway.
Interestingly, the CACNL1A2 and CACNL1A3 genes have a
second minor intron—a U12-type GT-AG intron—which falls
within domain repeat II (Table 3; Fig. 2). This type of intron
also has a precisely conserved position in all four known cal-
cium channel a subunit gene sequences (Fig. 3B). These ob-
servations led to the prediction that analogous U12-type
GT-AG introns may exist in other voltage-gated calcium chan-
nel a subunit genes. Alignment of the sequences of domain
repeats I and II shows that the two minor introns do not
interrupt a homologous position. The different location of
these introns within their respective domain repeats suggests
that they arose independently.
The SCN10A gene is also unusual in having three rare in-
trons out of a total of 26 introns (Fig. 2): the U12-type GT-AG
introns 2 and 8 (Tables 3 and 4) and the AT-AC II intron 24
(Table 6). The SCN4A intron 8 and SCN5A intron 9, which
correspond to SCN10A intron 8, are conventional GT-AG
introns. The voltage-gated calcium channel a subunit genes
lack an intron at the corresponding position. This sequence
comparison strongly suggests a shift from a U12-type GT-AG
intron to a conventional GT-AG intron by mutational drift
after the divergence of sodium and calcium channels from a
common ancestral gene.
The SCN4A, SCN5A, SCN8A, and SCN10A genes are para-
logues and belong to the voltage-gated sodium channel a sub-
unit gene family. The genomic organization of these four genes
is very similar (77, 88, 110). SCN4A, SCN5A, and SCN8A have
an AT-AC II intron at a homologous position (Table 6). In-
terestingly, the corresponding intron 24 of SCN10A has 59-AT
and AG-39 boundaries (Table 6) (88). All four introns inter-
rupt a homologous position of the coding sequence of their
FIG. 3. Conserved positions of unusual introns in voltage-gated ion channels. Multiple protein sequence alignments of the relevant regions of the voltage-gated
sodium and calcium channel a subunits are shown. The complete amino acid sequences encoded by the flanking exons were aligned by using the Genetics Computer
Group Pileup program, with a gap creation penalty of 12 and a gap extension penalty of 4 (23). The positions of the unusual introns in the corresponding genes are
indicated by the vertical black bar. Amino acid identities in more than half of the sequences are indicated by gray shading. Complete exon sequences are shown, except
where indicated. For each alignment, the intron position is also conserved at the nucleotide level (117). (A) Conserved positions of the minor AT-AC introns in eight
ion channel genes. Translations of the 59 portions of the calcium channel upstream exons are not shown in the alignment. The human SCN5A sequence is from reference
110; human SCN4A, mouse SCN8A, mouse SCN10A, and human CACNL1A1, CACNL1A2, CACNL1A3, and CACNL1A4 have GenBank accession no. L04216,
U59964, Y09108, AJ224873, D43706, U30666, and X99897, respectively. (B) Conserved positions of the minor U12-type GT-AG introns in four calcium channel genes.
Human CACNL1A1, CACNL1A2, CACNL1A3, and CACNL1A4 sequences have GenBank accession no. AJ224873, D43718, U30677, and X99897, respectively. (C)
Conserved positions of the AT-AC II introns in four sodium channel genes. Human SCN5A and SCN8A sequences are from references 110 and 77, respectively; human
SCN4A and mouse SCN10A sequences have GenBank accession no. L04233 and Y09108, respectively.
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respective gene (Fig. 3C). However, the voltage-gated calcium
channel a subunit genes lack an intron at the homologous
position (Fig. 2). Therefore, similar introns may exist in other
members of the voltage-gated sodium channel a subunit genes
but not in the voltage-gated calcium channel a subunit genes.
Because splicing of the corresponding AT-AC II introns of
SCN4A and SCN5A requires the major snRNAs, this is also
expected to be the case for SCN8A intron 21 and SCN10A
intron 24. The 59-AT and AG-39 boundaries of SCN10A intron
24 may represent an evolutionary transition between the cor-
responding AT-AC II introns and the major GT-AG introns.
In summary, the voltage-gated sodium and calcium a sub-
unit genes, which are derived from a common ancestral gene,
show an unusually high frequency of noncanonical introns. The
distribution of introns among the two gene families and indi-
vidual genes, the position of the introns within domain repeats
of the coding sequence, and the patterns of sequence diver-
gence at the intron ends provide interesting information about
the evolutionary history of minor introns.
CONCLUSION
Although the first examples of AT-AC intron sequences
were discovered only recently (28, 38, 100), a considerable
amount of information about the AT-AC pre-mRNA splicing
pathway has already been obtained. It is now known that
AT-AC introns are widespread in higher eukaryotes (86, 102,
120). The removal of AT-AC introns from pre-mRNA requires
the four minor U11, U12, U4atac, and U6atac snRNAs, which
play roles analogous to those of U1, U2, U4, and U6 snRNAs
in the major splicing pathway, and the major U5 snRNA, which
is the only snRNA component shared with the major spliceo-
some (reviewed in references 70 and 102). Both exon definition
interactions and purine-rich exonic enhancers stimulate
AT-AC splicing in vitro (119, 121). Therefore, they may con-
tribute to AT-AC splice site recognition in vivo.
Introns exist in the majority of eukaryotic cellular or viral
genes. The mechanisms of splicing, including both catalysis and
splice site selection, and the regulation of splicing are incom-
pletely understood at present. However, the identification and
characterization of some of the many protein factors involved
in splicing continue to provide important clues about splicing
and splice site selection mechanisms. The unexpected discov-
ery of the AT-AC splicing pathway provides additional chal-
lenges and opportunities for understanding splicing mecha-
nisms and specificity. Whereas the snRNAs involved in AT-AC
splicing have been identified, no information is currently avail-
able about snRNP and non-snRNP proteins involved in this
pathway. It will be especially interesting to determine whether
some protein components are shared between the two path-
ways, and/or whether novel components—which may or may
not resemble splicing factors in the conventional pathway—are
uniquely required for AT-AC splicing. Determining which
components are involved in interactions between the two path-
ways, such as in exon definition, should also be an important
priority. Identification and characterization of these compo-
nents should provide interesting insights into the mechanisms,
regulation, and evolution of pre-mRNA splicing.
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ADDENDUM
Shortly after this review was written, Burge et al. provided
an extensive classification of U12-type and U2-type introns on
the basis of a statistical analysis of 59-splice-site and branch site
sequences (9a). They describe instances of apparent intron
conversion from U12 type to U2 type during evolution by
examining introns of homologous or paralogous genes, and
they discuss models for the evolution of the major and minor
spliceosomes.
Comparison of the cDNA and genomic sequences (Gen-
Bank no. AF051782, AC005366, and AC005368) of HDIA1
(human diaphanous 1), a nonsyndromic deafness susceptibility
gene, reveals the presence of two AT-AC introns and one
GC-AG intron (118).
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